Prenetics Global Limited (PRENW)
USD 0.01
(19.0%)
USD 0.01
(19.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.82 Million USD | -93.29% |
| 2022 | 131.55 Million USD | 23.95% |
| 2021 | 106.13 Million USD | 302.85% |
| 2020 | 26.34 Million USD | 870.24% |
| 2019 | 2.71 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.78 Million USD | 41.66% |
| 2024 Q2 | 3.76 Million USD | -0.38% |
| 2023 Q1 | 7.88 Million USD | -70.81% |
| 2023 FY | 8.82 Million USD | -93.29% |
| 2023 Q3 | 1.62 Million USD | -24.01% |
| 2023 Q2 | 2.13 Million USD | -72.89% |
| 2023 Q4 | 2.67 Million USD | 64.47% |
| 2022 Q2 | 21.69 Million USD | -39.8% |
| 2022 Q1 | 36.03 Million USD | 51.64% |
| 2022 Q4 | 27 Million USD | -42.32% |
| 2022 FY | 131.55 Million USD | 23.95% |
| 2022 Q3 | 46.81 Million USD | 115.81% |
| 2021 Q2 | 34.69 Million USD | 58.15% |
| 2021 FY | 106.13 Million USD | 302.85% |
| 2021 Q1 | 21.93 Million USD | 157.38% |
| 2021 Q4 | 23.76 Million USD | -7.67% |
| 2021 Q3 | 25.73 Million USD | -25.8% |
| 2020 Q2 | 2.38 Million USD | 49.53% |
| 2020 Q1 | 1.59 Million USD | 0.0% |
| 2020 FY | 26.34 Million USD | 870.24% |
| 2020 Q4 | 8.52 Million USD | -38.42% |
| 2020 Q3 | 13.84 Million USD | 479.95% |
| 2019 FY | 2.71 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | 7.695% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 25.961% |
| CareDx, Inc | 178.32 Million USD | 95.048% |
| Exact Sciences Corporation | 1.84 Billion USD | 99.522% |
| Exagen Inc. | 29.45 Million USD | 70.023% |
| Inotiv, Inc. | 165.44 Million USD | 94.663% |
| Guardant Health, Inc. | 336.89 Million USD | 97.379% |
| Biodesix, Inc. | 36.07 Million USD | 75.525% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -564.152% |
| Precipio, Inc. | 6.01 Million USD | -46.725% |
| iSpecimen Inc. | 5.1 Million USD | -72.867% |
| Natera, Inc. | 492.74 Million USD | 98.208% |
| Aspira Women's Health Inc. | 5.26 Million USD | -67.805% |
| Standard BioTools Inc. | 50.45 Million USD | 82.498% |
| 23andMe Holding Co. | 99.37 Million USD | 91.115% |
| Castle Biosciences, Inc. | 174.8 Million USD | 94.949% |
| Personalis, Inc. | 18.2 Million USD | 51.505% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | 32.944% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -59.573% |
| OpGen, Inc. | -90.69 Thousand USD | 9835.911% |
| T2 Biosystems, Inc. | -8.17 Million USD | 208.077% |
| Myriad Genetics, Inc. | 476.4 Million USD | 98.147% |
| ICON Public Limited Company | 1.81 Billion USD | 99.513% |
| NeoGenomics, Inc. | 244.6 Million USD | 96.39% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 25.961% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 99.597% |
| RadNet, Inc. | 93 Million USD | 90.505% |
| MDxHealth SA | 43.92 Million USD | 79.9% |
| Psychemedics Corporation | 8.41 Million USD | -4.955% |
| Illumina, Inc. | 2.74 Billion USD | 99.678% |
| Check-Cap Ltd. | -212 Thousand USD | 4265.041% |
| Twist Bioscience Corporation | 133.34 Million USD | 93.378% |
| DarioHealth Corp. | 5.98 Million USD | -47.558% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 91.547% |
| Sera Prognostics, Inc. | 96 Thousand USD | -9097.799% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 3305.611% |
| OPKO Health, Inc. | 318.12 Million USD | 97.224% |
| Medpace Holdings, Inc. | 524.5 Million USD | 98.317% |
| Neogen Corporation | 463.9 Million USD | 98.097% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -519.369% |
| Prenetics Global Limited | 8.82 Million USD | 0.0% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -1632.509% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -1015.427% |
| Trinity Biotech plc | 19.45 Million USD | 54.602% |
| Neuronetics, Inc. | 51.7 Million USD | 82.923% |
| Sotera Health Company | 577.15 Million USD | 98.47% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -1015.427% |